Anthera Pharmaceuticals Inc Uncategorized Contracts & Agreements
48 Contracts & Agreements
- Letter Agreement between Anthera Pharmaceuticals, Inc. and Craig Thompson, dated June 15, 2018 (Filed With SEC on June 18, 2018)
- [remainder of page left blank intentionally.] (Filed With SEC on March 16, 2017)
- Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 (Filed With SEC on April 29, 2016)
- * * * * (Filed With SEC on March 14, 2016)
- Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 July 8, 2015 (Filed With SEC on August 10, 2015)
- CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on March 16, 2015)
- 655 MONTGOMERY STREET, SUITE 1190 SAN FRANCISCO, CA 94111-2658 (Filed With SEC on March 28, 2014)
- Exhibit No (Filed With SEC on August 9, 2011)
- Exhibit No (Filed With SEC on August 9, 2011)
- Exhibit No (Filed With SEC on August 9, 2011)
- CURRENT ASSETS (Filed With SEC on May 13, 2011)
- convenient, at-home, patient-administered subcutaneous dosing (Filed With SEC on October 22, 2010)
- ANTHERA PHARMACEUTICALS, INC. (Filed With SEC on September 22, 2010)
- CURRENT ASSETS (Filed With SEC on May 14, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on February 3, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
